Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-08 Purchase |
2022-08-10 8:49 pm |
Poseida Therapeutics Inc. | PSTX | Malin Life Sciences Holdings Ltd 10% Owner |
2,150,000 | $3.5 | $7,525,000 | 11,835,673 (Direct) |
View |
| 2022-08-08 Purchase |
2022-08-10 6:13 pm |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Executive Chairman 10% Owner |
142,857 | $3.5 | $500,000 | 9,398,519 (Indirect Direct) |
View |
| 2022-08-03 Sale |
2022-08-05 4:09 pm |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Executive Chairman 10% Owner |
160,696 | $3.689 | $592,808 | 9,255,662 (Indirect Direct) |
View |
| 2022-03-16 Purchase |
2022-03-18 8:01 pm |
Poseida Therapeutics Inc. | PSTX | Ingalls Kerry D. Chief Operating Officer |
3,000 | $3.98 | $11,940 | 55,000 (Direct) |
View |
| 2021-12-06 Purchase |
2021-12-07 06:03 am |
Poseida Therapeutics Inc. | PSTX | Malin Life Sciences Holdings Ltd Common director with Issuer Director 10% Owner |
1,828 | $6.9 | $12,613 | 9,685,673 (Direct) |
View |
| 2021-11-30 Purchase |
2021-12-02 6:33 pm |
Poseida Therapeutics Inc. | PSTX | Malin Life Sciences Holdings Ltd Common director with Issuer Director 10% Owner |
51,253 | $6.8522 | $351,194 | 9,683,845 (Direct) |
View |
| 2021-11-24 Purchase |
2021-11-29 7:55 pm |
Poseida Therapeutics Inc. | PSTX | Malin Life Sciences Holdings Ltd Common director with Issuer Director 10% Owner |
39,362 | $6.833 | $268,962 | 9,632,592 (Direct) |
View |
| 2021-11-19 Purchase |
2021-11-23 6:41 pm |
Poseida Therapeutics Inc. | PSTX | Malin Life Sciences Holdings Ltd Common director with Issuer Director 10% Owner |
25,729 | $7.0597 | $181,640 | 9,593,230 (Direct) |
View |
| 2021-11-17 Purchase |
2021-11-18 9:12 pm |
Poseida Therapeutics Inc. | PSTX | Ingalls Kerry D. Chief Operating Officer |
2,000 | $7 | $14,000 | 2,000 (Direct) |
View |
| 2021-11-16 Purchase |
2021-11-18 8:24 pm |
Poseida Therapeutics Inc. | PSTX | Malin Life Sciences Holdings Ltd Common director with Issuer Director 10% Owner |
379,376 | $7.201 | $2,731,889 | 9,567,501 (Direct) |
View |
| 2021-11-08 Sale |
2021-11-10 6:06 pm |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
18,924 | $7.09 | $134,171 | 5,806,212 (Indirect Direct) |
View |
| 2021-10-01 Sale |
2021-10-05 6:16 pm |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
20,029 | $7.02 | $140,604 | 5,794,256 (Indirect Direct) |
View |
| 2021-09-20 Sale |
2021-09-22 5:51 pm |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
20,000 | $8.001 | $160,020 | 9,483,661 (Indirect Direct) |
View |
| 2021-09-14 Sale |
2021-09-15 6:58 pm |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
20,000 | $8.1356 | $162,712 | 10,263,181 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-01 Option Award |
2023-03-02 6:28 pm |
N/A 2033-02-28 |
Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer |
218,055 | $0 | 302,914 (Direct) |
View |
| 2023-03-01 Tax Withholding |
2023-03-02 6:28 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer |
4,323 | $5.35 | 302,914 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-02 6:26 pm |
N/A 2033-02-28 |
Poseida Therapeutics Inc. | PSTX | LEONHARDT HARRY J GC & Chief Compliance Officer |
218,055 | $0 | 269,486 (Direct) |
View |
| 2023-03-01 Tax Withholding |
2023-03-02 6:26 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | LEONHARDT HARRY J GC & Chief Compliance Officer |
4,323 | $5.35 | 269,486 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-02 6:17 pm |
N/A 2033-02-28 |
Poseida Therapeutics Inc. | PSTX | Gergen Mark J President and CEO |
633,646 | $0 | 965,670 (Direct) |
View |
| 2023-02-01 Tax Withholding |
2023-02-03 4:19 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Director |
11,776 | $7 | 6,028,560 (Direct) |
View |
| 2023-02-01 Tax Withholding |
2023-02-03 4:16 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Gergen Mark J President and CEO |
31,819 | $7 | 330,314 (Direct) |
View |
Ownership |
2023-01-17 9:18 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Director |
0 | $0 | 6,040,336 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 10:44 am |
N/A 2032-06-15 |
Poseida Therapeutics Inc. | PSTX | Collins Cynthia Director |
48,150 | $0 | 48,150 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-16 8:59 pm |
N/A 2032-06-15 |
Poseida Therapeutics Inc. | PSTX | BAUM CHARLES M Director |
96,300 | $0 | 96,300 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-16 8:57 pm |
N/A 2032-06-15 |
Poseida Therapeutics Inc. | PSTX | Corning Luke Director |
48,150 | $0 | 48,150 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-16 8:56 pm |
N/A 2032-06-15 |
Poseida Therapeutics Inc. | PSTX | Schmid John P. Director |
48,150 | $0 | 48,150 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-16 8:54 pm |
N/A 2032-06-15 |
Poseida Therapeutics Inc. | PSTX | Lloyd Marcea Bland Director |
48,150 | $0 | 58,150 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-01 7:30 pm |
N/A 2032-02-29 |
Poseida Therapeutics Inc. | PSTX | LEONHARDT HARRY J GC & Chief Compliance Officer |
122,568 | $0 | 122,568 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-01 7:29 pm |
N/A 2032-02-29 |
Poseida Therapeutics Inc. | PSTX | Ingalls Kerry D. Chief Operating Officer |
122,568 | $0 | 124,568 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-01 7:28 pm |
N/A 2032-02-29 |
Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer |
122,568 | $0 | 156,799 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-01 7:28 pm |
N/A 2032-02-29 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
122,568 | $0 | 184,053 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-01 7:27 pm |
N/A 2032-02-29 |
Poseida Therapeutics Inc. | PSTX | Warner Brent President, Gene Therapy |
738,915 | $0 | 738,915 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-01 9:49 pm |
N/A 2032-01-31 |
Poseida Therapeutics Inc. | PSTX | Gergen Mark J President and CEO |
875,700 | $0 | 875,700 (Direct) |
View |
| 2021-12-30 Gift |
2022-02-01 9:48 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Executive Chairman 10% Owner |
142,857 | $0 | 9,542,858 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-01 9:48 pm |
N/A 2032-01-31 |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Executive Chairman 10% Owner |
219,000 | $0 | 9,542,858 (Direct) |
View |
| 2021-12-21 Exercise |
2021-12-22 4:53 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer |
2,616 | $1.173 | 38,047 (Direct) |
View |
| 2021-12-21 Exercise |
2021-12-22 4:53 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer |
3,100 | $1.933 | 38,047 (Direct) |
View |
| 2021-12-21 Exercise |
2021-12-22 4:53 pm |
N/A 2026-02-28 |
Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer |
5,716 | $0 | 38,047 (Direct) |
View |
| 2021-12-06 Exercise |
2021-12-08 8:38 pm |
N/A 2026-06-19 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
10,000 | $0 | 132,346 (Direct) |
View |
| 2021-12-06 Exercise |
2021-12-08 8:38 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
10,000 | $1.322 | 132,346 (Direct) |
View |
| 2021-11-19 Exercise |
2021-11-22 7:50 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
1,000 | $9.15 | 10,206,710 (Direct) |
View |
| 2021-11-19 Exercise |
2021-11-22 7:50 pm |
N/A 2031-02-03 |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
1,000 | $0 | 10,206,710 (Direct) |
View |
| 2021-11-01 Option Award |
2021-11-02 7:31 pm |
N/A 2031-10-31 |
Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer |
65,000 | $0 | 93,515 (Direct) |
View |
| 2021-10-11 Exercise |
2021-10-13 6:59 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
18,525 | $9.15 | 10,225,634 (Direct) |
View |
| 2021-10-11 Exercise |
2021-10-13 6:59 pm |
N/A 2031-02-03 |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
18,525 | $0 | 10,225,634 (Direct) |
View |
| 2021-09-13 Exercise |
2021-09-15 6:58 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
2,757 | $1.173 | 10,263,181 (Direct) |
View |
| 2021-09-13 Exercise |
2021-09-15 6:58 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
18,524 | $9.15 | 10,263,181 (Direct) |
View |
| 2021-09-13 Exercise |
2021-09-15 6:58 pm |
N/A 2026-02-28 |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
21,281 | $0 | 10,263,181 (Direct) |
View |
| 2021-09-09 Exercise |
2021-09-10 4:19 pm |
N/A 2026-06-19 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
10,000 | $0 | 132,346 (Direct) |
View |
| 2021-09-09 Exercise |
2021-09-10 4:19 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
10,000 | $1.322 | 132,346 (Direct) |
View |